FIRAPY Supports Clinical Research Advancing Non-Invasive Therapies for Peritoneal Dialysis
We are pleased to share that a new peer-reviewed clinical study, conducted in collaboration with
Taipei Veterans General Hospital, has been published in the Journal of the Formosan Medical Association (JFMA, 2025).
The study, titled
“Far-infrared therapy improves cardiovascular and infectious outcomes in peritoneal dialysis patients: A propensity-score matched cohort study,”
represents a significant milestone in FIRAPY’s ongoing academic engagement in dialysis-related research.
Long-Term Collaboration to Explore Non-Invasive Therapeutic Strategies
Over the past several years, the FIRAPY team has actively collaborated with hospital-based research groups and nephrology departments to support the development of non-invasive therapeutic approaches for dialysis patients. These joint research efforts have focused on key challenges in peritoneal dialysis, including:
- Inflammatory burden
- Cardiovascular complications
- Peritoneal membrane function
- Infection-related outcomes
This newly published study marks the sixth peer-reviewed paper supported by FIRAPY in this field and underscores our ongoing commitment to advancing scientific research that aims to improve patient outcomes through non-invasive care modalities.
About the Latest Publication
Led by the nephrology team at Taipei Veterans General Hospital, the study employed a propensity score-matched cohort design to evaluate long-term outcomes in peritoneal dialysis patients. The results suggest that the use of far-infrared therapy may be associated with reduced cardiovascular and infectious complications, offering promising insights for future clinical exploration.
We extend our sincere thanks to the research team at TVGH for their dedication and leadership, and we look forward to continuing our support for high-quality, collaborative research in kidney care.
Want to know more?
Contact us for more detail
